Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04017065 · ClinicalTrials.gov registry record
Prospective Multicenter Registry for Use of the MAXFRAME™ Multiaxial Correction System
A clinical trial, sponsored by AO Innovation Translation Center.
- Terminated
- Registry status
- 100
- Enrollment target
NCT04017065: Clinical Trial study, sponsored by AO Innovation Translation Center.
NCT04017065 is a clinical trial that was terminated before completion, run by AO Innovation Translation Center. The registered enrollment target is 100 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04017065 was terminated before completion, sponsored by AO Innovation Translation Center.
- TERMINATED
- Registry status
- 100 participants
- Enrollment target
Study Summary
The aim of this international, prospective, multicenter case series (patient registry) is to gather the first evidence on the use of the MAXFRAME™ system in normal clinical settings during deformity correction of both, the upper and lower limb, and gain information on indications, the handling of the device from the patients' and surgeons' perspective, as well as number of re-planning needed. It is planned to prospectively follow up to 100 patients treated with the MAXFRAME™ system. Information on patients entered into the registry will be collected from before the surgery until the removal of the device.
Primary Outcome
Demographics, medical history
Interventions
- DEVICE DePuy Synthes MAXFRAMETM system
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2020-10-01 |
| Est. Completion | 2021-06-11 |
Why NCT04017065 stopped before completion
NCT04017065 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which DePuy Synthes MAXFRAMETM system is the first listed.
NCT04017065 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04017065 about?
NCT04017065 is a clinical study titled "Prospective Multicenter Registry for Use of the MAXFRAME™ Multiaxial Correction System". The aim of this international, prospective, multicenter case series (patient registry) is to gather the first evidence on the use of the MAXFRAME™ system in normal clinical settings during deformity correction of both, the upper and lower limb, and gain information on indications, the handling of th...
What is the current status of trial NCT04017065?
This trial is currently terminated. The enrollment target is 100 participants. The study started on 2020-10-01. Estimated completion is 2021-06-11.
What interventions are being tested in trial NCT04017065?
The interventions under investigation include: DePuy Synthes MAXFRAMETM system (DEVICE).
Who is sponsoring clinical trial NCT04017065?
This trial is sponsored by AO Innovation Translation Center, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI